The world tried to kill Andy off but he had to stay alive to to talk about what happened with databases in 2025.

The value of servers shipped is also increasing, driven by the shift to AI servers that feature expensive GPUs. IDC predicts ...

Through a detailed examination of Microsoft, we can deduce the following trends: A Price to Earnings ratio of 33.77 significantly below the industry average by 0.6x suggests undervaluation. This can ...

Fox News is ending the year on a high note, scoring its best ratings ever in a non-election year while giving primetime broadcast networks a run for their money. According to Nielsen Media Research, ...

Follow ZDNET: Add us as a preferred source on Google. Hello, fellow humans! AI chatbots will soon replace us. They have access to more knowledge than our puny brains can hold, and they can easily be ...

In the fast-paced ecosystem of Silicon Valley, "data" isn’t just a buzzword—it’s the currency of innovation. But realizing you need a data-focused master’s degree is only the first step. The harder ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Fresh Start Women's Foundation ...

OpenSUSE and Manjaro are both powerhouse distributions. If you're new to Linux, only one of these may be right for you. These distributions are free to download and install. A long, long time ago, I ...

Another day, another update to Google's NotebookLM, the versatile AI tool that functions like a personal assistant focused only on you and your needs. The latest update is for visual learners: You can ...

On a cold winter’s day in December 1995, Microsoft co-founder Bill Gates shook the tech world with plans to embed internet connectivity into all of Microsoft’s major products, making headlines across ...

SAN FRANCISCO, Dec 3 (Reuters) - Nvidia (NVDA.O), opens new tab on Wednesday published new data showing that its latest artificial intelligence server can improve the performance of new models - ...

Ocrelizumab and rituximab, both anti-CD20 B-cell monoclonal antibodies, differ in molecular structure and safety profiles, impacting MS treatment outcomes. Retrospective data from the University of ...